STAT

NOVEMBER 25, 2024

UnitedHealth Group is paying many of its own physician practices significantly more than it pays other doctor groups in the same markets for similar services, undermining competition and driving up costs for consumers and businesses, a STAT investigation reveals.   The findings, drawn from a sample of practices across the country, expose the effects of a deepening conflict of interest: Rather than use its size and market power to drive down the cost of care, UnitedHealth, as the corpor

356

356

PharmaVoice

NOVEMBER 25, 2024

A prolific medical research and author, Martin Makary criticized the FDA and CDC for their decision-making during the pandemic, although he describes himself as pro-vaccine.

Vaccines 147

Vaccines 147

STAT

NOVEMBER 25, 2024

Should Robert F. Kennedy Jr. be confirmed as secretary of Health and Human Services, it will bring real political power to the network of wellness influencers who populate the Make America Health Again movement. Physicians like me are alarmed about many of Kennedy’s views on health. His anti-vaccination positions and his calls to prosecute medical journals, among other dangerous views, should never be normalized, are disqualifying for the position he seeks, and threaten to beat back decad

Diabetes 243

Diabetes Vaccines 243

Express Pharma

NOVEMBER 25, 2024

OneSource Specialty Pharma, an associate company of Strides, secured an equity commitment of $ 95 million from marquee investors at a pre-money equity valuation of $ 1.65 billion. The fundraising was led by HBM Healthcare Investments and associated investors, with additional participation inter alia from WhiteOak Capital, Param Capital, Motilal Oswal, Enam Holdings, SBI Life Insurance and Valuequest Investment Advisors.

97

97

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

NOVEMBER 25, 2024

Four years on, the Cassava Sciences story ended Monday exactly as many knew it would — with the company’s experimental drug for Alzheimer’s disease, simufilam, proving to be nothing more than a placebo in a large clinical trial.  The negative outcome is devastating for the nearly 2,000 participants in this study and a second study also shut down Monday.

236

236

Express Pharma

NOVEMBER 25, 2024

The United States Food and Drug Administration inspected Alembic Pharmaceuticals’ Solid Oral Formulation Facility (F-4) at Jarod. The scheduled GMP inspection was conducted from November 14, 2024, to November 22, 2024. The USFDA issued a Form 483 with five procedural observations. The post Alembic Pharma gets form 483 with five procedural observations by USFDA appeared first on Express Pharma.

97

97

Express Pharma

NOVEMBER 25, 2024

The Pharmaceuticals and Medical Devices Bureau of India (PMBI), the implementing agency of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is participating in the 43rd India International Trade Fair (IITF) 2024. The exhibition highlights the milestones and initiatives under PMBJP, emphasising the mission to provide quality and affordable medicines across India.

87

87

STAT

NOVEMBER 25, 2024

Minnesota hospitals participating in a controversial U.S. drug discount program reaped at least $630 million in revenue last year and the largest institutions were the biggest beneficiaries, according to a report from the Minnesota Department of Health. Specifically, hospitals received $1.5 billion in discounted medicines under the 340B Drug Discount program, but paid $734 million plus another $120 million to various parties for administration fees.

Hospitals 168

Hospitals Drug Pricing 168

pharmaphorum

NOVEMBER 25, 2024

IT industry group techUK has called on the government to guarantee funding for digital transformation and cyber resilience in health and social care.

82

82

Express Pharma

NOVEMBER 25, 2024

Biologic therapies are revolutionising severe asthma management by targeting specific inflammatory pathways, shifting care from symptom control to potential remission. Real-world evidence underscores their efficacy across diverse patient profiles, including those with complex asthma cases. However, barriers such as cost and accessibility persist, highlighting the urgent need for equitable healthcare solutions to ensure widespread adoption of these transformative treatments, according to GlobalDa

71

71

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

BioPharma Dive

NOVEMBER 25, 2024

The setback likely removes one competitor to an emerging spinal muscular atrophy medicine from Scholar Rock, but sets the stage for a pair of readouts with implications for weight loss research.

67

67

Express Pharma

NOVEMBER 25, 2024

Merck Life Science in India signed a Memorandum of Understanding (MoU) with GeNext Genomics, an emerging biotech company. This collaboration aims to combine local expertise with global biomanufacturing capabilities The MoU was signed between Aditya Sharma, Head of Process Solutions, India Region, Merck Life Science; Dr Ashwin Kashikar, Managing Director, Genext Genomics; Supriya Kashikar, Founder & CEO, GeNext Genomics and Ravi Kashikar, Chairman and Founder of Ankur Seeds.

63

63

BioPharma Dive

NOVEMBER 25, 2024

Positive results from a study of Winrevair could help the drugmaker achieve sales growth past top-seller Keytruda’s upcoming patent expirations this decade.

67

67

The Pharmacist

NOVEMBER 25, 2024

Boots has launched a private respiratory syncytial virus (RSV) vaccination service priced at £245. The chain claims it has become the ‘first multiple pharmacy’ to launch such a service. It comes as the UK Health Security Agency (UKHSA) warned RSV was circulating above baseline levels, with particularly pronounced increases in those under five years old. […] The post Boots launches private RSV vaccination service appeared first on The Pharmacist.

Vaccines 62

Vaccines 62

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

pharmaphorum

NOVEMBER 25, 2024

After a disappointing result with Truqap in triple-negative breast cancer, AstraZeneca chalks up a win in prostate cancer.

77

77

Pharmafile

NOVEMBER 25, 2024

Langland, a medical life sciences company with focuses on areas surrounding Clinical Trial experience, Medical Strategy and Education, Public Relations and Engagement and Advertising, has announced the appointment of Gemma Cathcart as managing partner for the Advertising sector. Gemma, who has held previous roles such as managing partner of Global Health from Avalere Health and […] The post Gemma Cathcart appointed managing partner at Langland appeared first on Pharmafile.

59

59

pharmaphorum

NOVEMBER 25, 2024

Watch this exclusive interview with health innovators Lori Fletcher and Amber Beimer from Advanced Clinical as they discuss the latest trends and advancements in the Functional Service Provider (FSP) field.

59

59

Putting Patients First Blog

NOVEMBER 25, 2024

NHC CEO Affinity Group Meeting - Executive Dialogue with NAHPC Event Time: 2:00 - 3:30 p.m. ET Event Location: Virtual The CEO Affinity Group is designed to provide a dedicated forum for patient organization CEOs and partners to engage in executive dialogue, share insights, and collaborate on key issues impacting the patient community. This CEO-only session will conclude the 2024 Access Working Group series and reinstate a highly effective tradition of peer-to-peer engagement, with plans to conv

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

NOVEMBER 25, 2024

Halozyme Therapeutics has withdrawn its offer to acquire Evotec, saying that the German company had been unwilling to engage with negotiations.

66

66

Putting Patients First Blog

NOVEMBER 25, 2024

New NHC Resources Help Families Make Sense of Medicare Changes November 25, 2024 By: Susan Gaffney, Executive Vice President I’ve spent the past 15 years living as a poster child for the sandwich generation. My children were born just as my parents were becoming increasingly incapacitated by age and chronic disease. I was checking out assisted living facilities while baby-wearing a newborn and my double stroller had to squeeze in my minivan trunk with a walker and a wheelchair.

Assisted Living 52

Assisted Living 52

Pharmaceutical Commerce

NOVEMBER 25, 2024

In the second part of this roundtable discussion, key opinion leaders discuss the potential technological challenges surrounding RFID, and the likelihood of not only utilizing this tech at the item level but for product security purposes as well.

52

52

Pharmaceutical Business Review

NOVEMBER 25, 2024

The approval makes the company the first commercial biotech to receive such a license for this cell therapy type. Derived from the umbilical cord blood of humans, the allogeneic hematopoietic stem cell therapy REGENECYTE is currently approved for use in unrelated donor hematopoietic progenitor cell transplantation. The therapy is intended for patients with hematopoietic system disorders, whether inherited, acquired, or resulting from myeloablative treatments.

Immunity 52

Immunity Immunization 52

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

European Pharmaceutical Review

NOVEMBER 25, 2024

The pharmaceutical analytical testing market is seeing significant growth following a greater incidence in the complexity of medicine development and higher demand for biologics and biosimilars, according to a report by Straits Research Pvt. Ltd. Their analysis projected that the market will exceed a value of $15.46 billion by 2032. The market is furthermore expected to see a compound annual growth rate (CAGR) of 7.3 percent between 2024 and 2032.

Drug Development 52

Drug Development Biosimilars Compounding Pharmaceutical Companies 52

Fuld & Company Blog

NOVEMBER 25, 2024

This month we look to the future by helping you prepare for what’s next with scenario planning, and also by examining how the energy transition is reshaping industries and driving sustainability. Explore the potential of Small Modular Reactors (SMRs) to meet growing energy needs, see how companies are advancing toward net zero, and learn how to develop resilient, data-backed strategies for your business in our upcoming webinar, Scenario planning to prepare for the next disruption.

52

52

pharmaphorum

NOVEMBER 25, 2024

BridgeBio grabs FDA approval for its ATTR cardiomyopathy drug Attruby, setting up a challenge to market leader Pfizer

66

66

PharmExec

NOVEMBER 25, 2024

Pathway is now the first and only FDA-approved companion diagnostic for identifying HER2-positive biliary tract cancer patients eligible for treatment with Ziihera.

Labelling 52

Labelling 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharmaceutical Technology

NOVEMBER 25, 2024

GSK has received approval from Japan's MHLW for its application to extend the indication of its RSV vaccine, Arexvy.

Vaccines 59

Vaccines 59

The Pharmacist

NOVEMBER 25, 2024

GP leaders in England have voted in favour of terminating pharmacy blood pressure checks with ‘immediate effect’. The British Medical Associations (BMA) Local Medical Committee (LMC) Conference saw GPs debate community pharmacy funding and place emphasis on the sector’s ‘core work’ of dispensing. The motion, proposed by Devon LMC, suggested that pharmacy blood pressure checks […] The post GP leaders vote to ‘terminate’ pharmacy blood pressure checks appeared first on The Pharmacist.

Community Pharmacies 51

Community Pharmacies 51

Pharma Times

NOVEMBER 25, 2024

Commit Biologics has appointed Mikkel Wandahl Pedersen as CSO

72

72

PharmExec

NOVEMBER 25, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Pharmaceutical Technology

NOVEMBER 25, 2024

The biopharmaceutical industry is being called to take its sustainability efforts to the next level. A new report sheds light on the topic.

52

52